ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Two Studies Advance The Treatment Of Early-Stage And Later Breast Cancer

June 27, 2008

Overall Cancer Mortality Rates Higher For Men Than Women

July 29, 2011

In Brief DCCP Directorship Draws 100 Names; Upon Agrees Centers Programs Needs More Staff

January 13, 1978

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002